Abstract
It has been reported previously that Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist HU-210 [(−)-11-OH-Δ8-dimethylheptyl tetrahydrocannabinol] prevent long-term potentiation (LTP) induction in rat hippocampal slices. In this study we confirm that both WIN55212-2 {R-(+)-(2,3-dihydro-5-methyl-3-[{4-morpholinyl} methyl] pyrol [1,2,3-de]-1,4-benzoxazin-6-yl) (1-naphtalenyl) methanone monomethanesulphonate} (3 and 10 μM), another synthetic cannabinoid agonist, and anandamide (10 μM), considered to be the endogenous ligand of cannabinoid receptors, inhibit LTP formation in the Schaffer collateral-CA1 field complex. In addition, we show that SRt417l6A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-lH-pyrazole-3-carboxamide hydrochloride] at 0.1–10 μM, a potent and selective antagonist of CB1 cannabinoid receptors, concentration-dependently reversed the inhibition of LTP induced by both WIN55212-2 and anandamide. These data indicate that cannabinoid receptor agonists inhibit hippocampal LTP formation through CB1 receptor activation and that anandamide could be a candidate for an endogenous neuromessenger involved in memory processes.
References
Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39
Childers SR, Tammy T, Roy MR (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 47:711–715
Collin C, Devane WA, Lee CJ, Axelrod J, Alkon DL (1994) Longterm transformation of hippocampal GABAergic synapses and the role of anandamide, an endogenous cannabinoid ligand. Soc Neurosci Abstr 1:652
Collins DR, Pertwee RG, Davies SN (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 259:7–8
Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (1993) Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46:967–972
Deahl M (1991) Cannabis and memory loss (editorial), Br J Addict 86:249–252
Devane WA, Dysarz FA III, Jonhson MR, Melvin LS and Howlett AC (1992) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686–691
Herkenham M (1992) Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci 54:19–32
Heyser CJ, Hampson RE, Deadwyler SA (1992) Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264:294–307
Miller LL, Branconnier RJ (1983) Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull 93:441–456
Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 19:663–672
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrié P, Breliére JC, Le Fur G (1994) SR141716A, a potent and elective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240–244
Wilkison DM, Pontzer NJ (1987) The actions of THC on the intact hippocampus: a comparison of dentate and CA1 responses. Brain Res Bull 19:63–67
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Terranova, JP., Michaud, JC., Le Fur, G. et al. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 352, 576–579 (1995). https://doi.org/10.1007/BF00169393
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169393